Information Provided By: 
Fly News Breaks for June 1, 2018
ANTH, AZRX
Jun 1, 2018 | 07:57 EDT
H.C. Wainwright analyst Raghuram Selvaraju noted that AzurRx BioPharma (AZRX) hired Dr. James Pennington, who was previously Chief Medical Officer and later Senior Clinical Fellow at Anthera Pharmaceuticals (ANTH), as the company's CMO. The fact that an experience CMO such as Dr. Pennington agreed to join AzurRx adds incremental validation to MS1819, the company's candidate for EPI associated with chronic pancreatitis and cystic fibrosis, said Selvaraju, who keeps a Buy rating on AzurRx shares.
News For AZRX;ANTH From the Last 2 Days
There are no results for your query AZRX;ANTH
